Vasodilator therapy in coronary artery disease. Part II. 1977

W D Hager

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014665 Vasodilator Agents Drugs used to cause dilation of the blood vessels. Vasoactive Antagonists,Vasodilator,Vasodilator Agent,Vasodilator Drug,Vasorelaxant,Vasodilator Drugs,Vasodilators,Vasorelaxants,Agent, Vasodilator,Agents, Vasodilator,Antagonists, Vasoactive,Drug, Vasodilator,Drugs, Vasodilator

Related Publications

W D Hager
January 1986, The Journal of emergency medicine,
W D Hager
July 1959, Monthly bulletin of the Ministry of Health and the Public Health Laboratory Service,
W D Hager
January 1979, Heart & lung : the journal of critical care,
W D Hager
May 1959, British medical journal,
W D Hager
March 1989, Kyobu geka. The Japanese journal of thoracic surgery,
W D Hager
March 2021, The International journal of angiology : official publication of the International College of Angiology, Inc,
W D Hager
May 2001, The Western journal of medicine,
Copied contents to your clipboard!